147 related articles for article (PubMed ID: 32264772)
1. Investigation of the effects of cannabidiol on vacuous chewing movements, locomotion, oxidative stress and blood glucose in rats treated with oral haloperidol.
Kajero JA; Seedat S; Ohaeri J; Akindele A; Aina O
World J Biol Psychiatry; 2020 Oct; 21(8):612-626. PubMed ID: 32264772
[No Abstract] [Full Text] [Related]
2. Cannabidiol prevents haloperidol-induced vacuos chewing movements and inflammatory changes in mice via PPARγ receptors.
Sonego AB; Prado DS; Vale GT; Sepulveda-Diaz JE; Cunha TM; Tirapelli CR; Del Bel EA; Raisman-Vozari R; Guimarães FS
Brain Behav Immun; 2018 Nov; 74():241-251. PubMed ID: 30217539
[TBL] [Abstract][Full Text] [Related]
3. PPARγ receptors are involved in the effects of cannabidiol on orofacial dyskinesia and cognitive dysfunction induced by typical antipsychotic in mice.
Sonego AB; Prado DDS; Guimarães FS
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Dec; 111():110367. PubMed ID: 34048863
[TBL] [Abstract][Full Text] [Related]
4. Effects of cannabidiol on vacuous chewing movements, plasma glucose and oxidative stress indices in rats administered high dose risperidone.
Kajero JA; Seedat S; Ohaeri J; Akindele A; Aina O
Sci Rep; 2022 Nov; 12(1):19718. PubMed ID: 36385633
[TBL] [Abstract][Full Text] [Related]
5. Protective role of endocannabinoid signaling in an animal model of haloperidol-induced tardive dyskinesia.
Röpke J; Ferreira-Vieira TH; Iglesias LP; Asth L; Ribeiro FM; Moreira FA
Pharmacol Biochem Behav; 2021 Jul; 206():173193. PubMed ID: 33933537
[TBL] [Abstract][Full Text] [Related]
6. Electron spin resonance spectroscopy reveals alpha-phenyl-N-tert-butylnitrone spin-traps free radicals in rat striatum and prevents haloperidol-induced vacuous chewing movements in the rat model of human tardive dyskinesia.
Rogoza RM; Fairfax DF; Henry P; N-Marandi S; Khan RF; Gupta SK; Mishra RK
Synapse; 2004 Dec; 54(3):156-63. PubMed ID: 15452862
[TBL] [Abstract][Full Text] [Related]
7. Oral administration of haloperidol at clinically recommended doses elicits smaller parkinsonian effects but more tardive dyskinesia in rats.
Shireen E; Naeem S; Inam QU; Haleem DJ
Pak J Pharm Sci; 2013 Mar; 26(2):271-6. PubMed ID: 23455196
[TBL] [Abstract][Full Text] [Related]
8. Quercetin, a bioflavonoid, attenuates haloperidol-induced orofacial dyskinesia.
Naidu PS; Singh A; Kulkarni SK
Neuropharmacology; 2003 Jun; 44(8):1100-6. PubMed ID: 12763102
[TBL] [Abstract][Full Text] [Related]
9. Anandamide attenuates haloperidol-induced vacuous chewing movements in rats.
Röpke J; Busanello A; Leal CQ; de Moraes Reis E; de Freitas CM; Villarinho JG; Figueira FH; Mello CF; Ferreira J; Fachinetto R
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():195-9. PubMed ID: 24747871
[TBL] [Abstract][Full Text] [Related]
10. The effects of cannabidiol on behavioural and oxidative stress parameters induced by prolonged haloperidol administration.
Kajero JA; Seedat S; Ohaeri JU; Akindele A; Aina O
Acta Neuropsychiatr; 2022 Nov; ():1-11. PubMed ID: 36328984
[TBL] [Abstract][Full Text] [Related]
11. Lipoic acid and haloperidol-induced vacuous chewing movements: Implications for prophylactic antioxidant use in tardive dyskinesia.
Lister J; Andreazza AC; Navaid B; Wilson VS; Teo C; Nesarajah Y; Wilson AA; Nobrega JN; Fletcher PJ; Remington G
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jan; 72():23-29. PubMed ID: 27565433
[TBL] [Abstract][Full Text] [Related]
12. Ginkgo biloba leaf extract and alpha-tocopherol attenuate haloperidol-induced orofacial dyskinesia in rats: Possible implication of antiapoptotic mechanisms by preventing Bcl-2 decrease and Bax elevation.
An HM; Tan YL; Shi J; Wang Z; Lv MH; Soares JC; Zhou D; Yang F; Zhang XY
Phytomedicine; 2016 Dec; 23(13):1653-1660. PubMed ID: 27823630
[TBL] [Abstract][Full Text] [Related]
13. Excitatory mechanisms in neuroleptic-induced vacuous chewing movements (VCMs): possible involvement of calcium and nitric oxide.
Naidu PS; Kulkarni SK
Behav Pharmacol; 2001 Jun; 12(3):209-16. PubMed ID: 11485057
[TBL] [Abstract][Full Text] [Related]
14. Effect of 5-HT1A and 5-HT2A/2C receptor modulation on neuroleptic-induced vacuous chewing movements.
Naidu PS; Kulkarni SK
Eur J Pharmacol; 2001 Sep; 428(1):81-6. PubMed ID: 11779040
[TBL] [Abstract][Full Text] [Related]
15. Relationship of orofacial movements to behavioural repertoire as assessed topographically over the course of 6-month haloperidol treatment followed by 4-month withdrawal.
De Souza IE; Dawson NM; Clifford JJ; Waddington JL; Meredith GE
Psychopharmacology (Berl); 2003 Aug; 169(1):28-34. PubMed ID: 12830366
[TBL] [Abstract][Full Text] [Related]
16. Extract of Ginkgo biloba is equivalent to vitamin E in attenuating and preventing vacuous chewing movements in a rat model of tardive dyskinesia.
An HM; Tan YL; Shi J; Wang ZR; Li J; Wang YC; Kosten TR; Zhou DF; Yang FD; Zhang XY
Behav Pharmacol; 2013 Oct; 24(7):610-6. PubMed ID: 23994817
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological and neurochemical differences between acute and tardive vacuous chewing movements induced by haloperidol.
Egan MF; Hurd Y; Ferguson J; Bachus SE; Hamid EH; Hyde TM
Psychopharmacology (Berl); 1996 Oct; 127(4):337-45. PubMed ID: 8923569
[TBL] [Abstract][Full Text] [Related]
18. The rat model of tardive dyskinesia: relationship between vacuous chewing movements and gross motor activity during acute and long-term haloperidol treatment.
Andreassen OA; Jørgensen HA
Life Sci; 1995; 57(24):2263-72. PubMed ID: 7475980
[TBL] [Abstract][Full Text] [Related]
19. Effect of spirulina maxima on the haloperidol induced tardive dyskinesia and oxidative stress in rats.
Thaakur SR; Jyothi B
J Neural Transm (Vienna); 2007 Sep; 114(9):1217-25. PubMed ID: 17530160
[TBL] [Abstract][Full Text] [Related]
20. Mixture in the distribution of haloperidol-induced oral dyskinesias in the rat supports an animal model of tardive dyskinesia.
Hashimoto T; Ross DE; Gao XM; Medoff DR; Tamminga CA
Psychopharmacology (Berl); 1998 May; 137(2):107-12. PubMed ID: 9629996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]